August 12, 2026

Merck Animal Health Announces USDA Approval of INNOVAX® ND-IBD-ILT

August 4, 2026

Merck Animal Health Supports Future Poultry Veterinarians with $50,000 in Scholarships

July 6, 2026

Merck Animal Health Announces EXZOLT® (fluralaner oral solution) for Northern Fowl Mites in Backyard Chickens

June 11, 2026

Merck Animal Health to Acquire TARGAN

June 4, 2026

Merck Animal Health Reinforces Commitment to Help Protect U.S. Livestock from New World Screwworm Threat

May 5, 2026

In Observance of Mental Health Awareness Month, Merck Animal Health Announces Inaugural Veterinary Wellbeing Collective to Help Advance Veterinary Wellbeing

March 18, 2026

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

March 4, 2026

Merck Animal Health Awards $50,000 in Scholarships to Five Next Generation Swine Veterinarians

February 27, 2026

FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health

The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis

December 12, 2025

Merck Animal Health Announces Availability of Circumvent® CL, a Ready-to-use Vaccine Protecting Pigs Against Porcine Circovirus Types 2a and 2d and Lawsonia intracellularis

December 4, 2025

FDA Conditionally Approves Merck Animal Health’s EXZOLT® CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)

November 6, 2025

Merck Animal Health Donates $20,000 to the University of Nebraska–Lincoln Klosterman Feedlot Innovation Center to Advance Sustainability-focused Research for Feedlot Cattle